This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Reviewing your finances regularly is essential for success. Explore various ways to conduct reviews and enhance your financial strategy.
18,365 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
As May 14 approaches, investors weigh growth momentum, profitability, and AI competition around figma's next earnings...
Investors are eyeing Atour's Q1 2026 updates. This guide explains how to read the atour (atat) 2026 earnings narrativ...
A respected analyst has earmarked Dutch Bros as the best restaurant stock pick, citing traffic gains, digital momentu...
Niche energy tech stocks can surge on fresh coverage and bullish notes. This guide explains why the nano nuclear ener...
Palantir stock today climbed as the company announced a strategic AI collaboration. This article breaks down the driv...
A seasoned investor’s eye looks beyond a single insider trade. This article breaks down why this limited insider sale...
Gold has emerged as a standout performer in 2026, with certain bullion-backed ETFs delivering resilience and steady g...
Ohio is poised to boost its innovation engine. By conforming to the federal R&E immediate cost recovery rules, oh...
With earnings on the horizon and a bold pivot to AI infrastructure, investors face a tough call. This guide breaks do...
A sudden 47% rise in Structure Therapeutics stock has traders buzzing while a major fund exits a multi-million dollar...
A big institutional purchase in ENOV has investors buzzing. This article breaks down what the move could signal, how ...